ESC 365 - A new approach in CVD risk management, the role of pharmacists

EAPC Premium Access

A new approach in CVD risk management, the role of pharmacists

Event: EuroPrevent 2017

Topic: Public health and health policy

Session type: Symposium

Date: 6 April 2017

Time: 16:30 - 18:00

Session

4 presentations in this session

The effectiveness of pharmacist interventions on cardiovascular risk.

Speaker: Professor R. Tsuyuki (Edmonton, CA)

Cardiovascular risk assessment and effects on behavior in Switzerland: the CardioTest.

Speaker: Professor O. Pfister (Basel, CH)

Check-up your heart health at Swedish pharmacies.

Speaker: Mrs M. Norelius (Lidingo, SE)

Do Greek pharmacists have a role in CVD prevention? A pharmacy-led weight management Programme.

Speaker: Doctor A. Peletidi (Kingston upon Thames, GB)

Speaker: Doctor R. Kayyali (Kingston Upon Thames, GB)

5 speakers from this session

Professor Ross Tsuyuki

, Edmonton (Canada)

1 presentation

0 follower

Professor Otmar Pfister

University Hospital Basel, Basel (Switzerland)

1 presentation

0 follower

Mrs Marianne Norelius

, Lidingo (Sweden)

1 presentation

0 follower

Doctor Aliki Peletidi

Kingston University, Kingston upon Thames (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

Doctor Reem Kayyali

, Kingston Upon Thames (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

This platform is supported by